Literature DB >> 9305962

Purine nucleoside phosphorylase. 1. Structure-function studies.

M D Erion1, K Takabayashi, H B Smith, J Kessi, S Wagner, S Hönger, S L Shames, S E Ealick.   

Abstract

To probe the catalytic mechanism of human purine nucleoside phosphorylase (PNP), 13 active-site mutants were constructed and characterized by steady-state kinetics. In addition, microtiter plate assays were developed for both the phosphorolytic and synthetic reactions and used to determine the kinetic parameters of each mutant. Mutations in the purine binding site exhibited the largest effects on enzymatic activity with the Asn243Ala mutant resulting in a 1000-fold decrease in the kcat for inosine phosphorolysis. This result in combination with the crystallographic location of the Asn243 side chain suggested a potential transition state (TS) structure involving hydrogen bond donation by the carboxamido group of Asn243 to N7 of the purine base. Analogous to the oxyanion hole of serine proteases, this hydrogen bond was predicted to aid catalysis by preferentially stabilizing the TS as a consequence of the increase in negative charge on N7 that occurs during glycosidic bond cleavage and the associated increase in the N7-Asn243 hydrogen bond strength. Two residues in the phosphate binding site, namely His86 and Glu89, were also predicted to be catalytically important based on their alignment with phosphate in the X-ray structure and the 10-25-fold reduction in catalytic activity for the His86Ala and Glu89Ala mutants. In contrast, catalytic efficiencies for the Tyr88Phe and Lys244Ala mutants were comparable with wild-type, indicating that the hydrogen bonds predicted in the initial X-ray structure of PNP [Ealick, S. E., et al. (1990) J. Biol. Chem. 265, 1812-1820] were not essential for catalysis. These results provided the foundation for studies reported in the ensuing two manuscripts focused on the PNP catalytic mechanism [Erion, M. D., et al. (1997) Biochemistry 36, 11735-11748] and the use of mutagenesis to reverse the PNP substrate specificity from 6-oxopurines to 6-aminopurines [Stoeckler, J. D., et al. (1997) Biochemistry 36, 11749-11756].

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9305962     DOI: 10.1021/bi961969w

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  31 in total

1.  Identification of the tautomeric form of formycin A in its complex with Escherichia coli purine nucleoside phosphorylase based on the effect of enzyme-ligand binding on fluorescence and phosphorescence.

Authors:  Jakub Włodarczyk; Gerasim Stoychev Galitonov; Borys Kierdaszuk
Journal:  Eur Biophys J       Date:  2003-12-04       Impact factor: 1.733

2.  Neighboring group participation in the transition state of human purine nucleoside phosphorylase.

Authors:  Andrew S Murkin; Matthew R Birck; Agnes Rinaldo-Matthis; Wuxian Shi; Erika A Taylor; Steven C Almo; Vern L Schramm
Journal:  Biochemistry       Date:  2007-04-04       Impact factor: 3.162

3.  Design and directed evolution of a dideoxy purine nucleoside phosphorylase.

Authors:  David P Nannemann; Kristian W Kaufmann; Jens Meiler; Brian O Bachmann
Journal:  Protein Eng Des Sel       Date:  2010-06-04       Impact factor: 1.650

4.  Arsenate and phosphate as nucleophiles at the transition states of human purine nucleoside phosphorylase.

Authors:  Rafael G Silva; Jennifer S Hirschi; Mahmoud Ghanem; Andrew S Murkin; Vern L Schramm
Journal:  Biochemistry       Date:  2011-03-10       Impact factor: 3.162

5.  Structural basis of the substrate specificity of Bacillus cereus adenosine phosphorylase.

Authors:  Paola Dessanti; Yang Zhang; Simone Allegrini; Maria Grazia Tozzi; Francesco Sgarrella; Steven E Ealick
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2012-02-14

6.  The crystal structure of Streptococcus pyogenes uridine phosphorylase reveals a distinct subfamily of nucleoside phosphorylases.

Authors:  Timothy H Tran; S Christoffersen; Paula W Allan; William B Parker; Jure Piskur; I Serra; M Terreni; Steven E Ealick
Journal:  Biochemistry       Date:  2011-07-08       Impact factor: 3.162

7.  Four generations of transition-state analogues for human purine nucleoside phosphorylase.

Authors:  Meng-Chiao Ho; Wuxian Shi; Agnes Rinaldo-Matthis; Peter C Tyler; Gary B Evans; Keith Clinch; Steven C Almo; Vern L Schramm
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-08       Impact factor: 11.205

8.  Activity-based protein profiling of the hepatitis C virus replication in Huh-7 hepatoma cells using a non-directed active site probe.

Authors:  Ragunath Singaravelu; David R Blais; Craig S McKay; John Paul Pezacki
Journal:  Proteome Sci       Date:  2010-02-04       Impact factor: 2.480

9.  Lupus-Associated Functional Polymorphism in PNP Causes Cell Cycle Abnormalities and Interferon Pathway Activation in Human Immune Cells.

Authors:  Yogita Ghodke-Puranik; Jessica M Dorschner; Danielle M Vsetecka; Shreyasee Amin; Ashima Makol; Floranne Ernste; Thomas Osborn; Kevin Moder; Vaidehi Chowdhary; Elias Eliopoulos; Maria I Zervou; George N Goulielmos; Mark A Jensen; Timothy B Niewold
Journal:  Arthritis Rheumatol       Date:  2017-11-09       Impact factor: 10.995

10.  Cloning, purification and characterisation of a recombinant purine nucleoside phosphorylase from Bacillus halodurans Alk36.

Authors:  Daniel F Visser; Fritha Hennessy; Konanani Rashamuse; Maureen E Louw; Dean Brady
Journal:  Extremophiles       Date:  2010-03       Impact factor: 2.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.